J&J Unit's Stelara Infringes Abbott Patents, Judge Rules
A Massachusetts federal judge ruled Friday on several competing summary judgment bids in a legal battle between Abbott GmbH & Co. KG and Johnson & Johnson unit Janssen Biotech Inc., finding...To view the full article, register now.
Already a subscriber? Click here to view full article